The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
Rapporti ISTISAN 18/4
Questo volume raccoglie le relazioni presentate in occasione del corso residenziale “Attività di controllo su prodotti biocidi...
Negli ultimi decenni è stato osservato un aumento della diffusione della pratica del tatuaggio considerata, allo stato attuale, ...
Guidelines for good practice
How are chemicals safely stored?
This question is relevant not only in chemical plants; the products in the following examples are also chemicals:
- Pai...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
